S100A9 and head and neck cancer: Interestingly, Gabrilovich et al. have shown that the presence of S100A9-positive macrophages was predictive of a poor clinical outcome in patients with head and neck cancer and of a poor response to ICB in patients with metastatic melanoma [49].